Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Alvarez

Showing results (371-380 of 382) with videos related to

Pageof 39
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|May 9, 2025
Patient-Reported Outcomes on Food Immunotherapy Differ Between Countries and Foods: Results From COFAITHPablo Rodríguez Del Río, Carmen Riggioni, Antoine Deschildre, et al.
Allergy|June 24, 2019
The role of mobile health technologies in allergy care: An EAACI position paperPaolo Maria Matricardi, Stephanie Dramburg, Alberto Alvarez-Perea, et al.
Cancers|February 25, 2023
Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase InhibitorsLucía Pérez-Lamas, Alejandro Luna, Concepción Boque, et al.
Leukemia|January 8, 2021
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinibTiziano Barbui, Alessandro Maria Vannucchi, Alberto Alvarez-Larran, et al.
Blood Cancer Journal|February 10, 2021
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19Tiziano Barbui, Valerio De Stefano, Alberto Alvarez-Larran, et al.
Blood Cancer Journal|June 17, 2021
Long-term follow-up of recovered MPN patients with COVID-19Tiziano Barbui, Alessandra Iurlo, Arianna Masciulli, et al.
American Journal of Hematology|September 16, 2022
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19Tiziano Barbui, Alessandra Carobbio, Arianna Ghirardi, et al.
Blood Cancer Journal|November 15, 2022
Breakthrough infections in MPN-COVID vaccinated patientsTiziano Barbui, Alessandra Carobbio, Arianna Ghirardi, et al.
Leukemia|January 22, 2022
Second versus first wave of COVID-19 in patients with MPNTiziano Barbui, Alessandra Iurlo, Arianna Masciulli, et al.
Allergy|October 30, 2024
EAACI guidelines on the management of IgE-mediated food allergyAlexandra F Santos, Carmen Riggioni, Ioana Agache, et al.
Pageof 39

Showing results (371-380 of 382) with videos related to

Sort By:
Pageof 39
The Journal of Allergy and Clinical Immunology. in Practice|May 9, 2025
Patient-Reported Outcomes on Food Immunotherapy Differ Between Countries and Foods: Results From COFAITHPablo Rodríguez Del Río, Carmen Riggioni, Antoine Deschildre, et al.
Allergy|June 24, 2019
The role of mobile health technologies in allergy care: An EAACI position paperPaolo Maria Matricardi, Stephanie Dramburg, Alberto Alvarez-Perea, et al.
Cancers|February 25, 2023
Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase InhibitorsLucía Pérez-Lamas, Alejandro Luna, Concepción Boque, et al.
Leukemia|January 8, 2021
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinibTiziano Barbui, Alessandro Maria Vannucchi, Alberto Alvarez-Larran, et al.
Blood Cancer Journal|February 10, 2021
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19Tiziano Barbui, Valerio De Stefano, Alberto Alvarez-Larran, et al.
Blood Cancer Journal|June 17, 2021
Long-term follow-up of recovered MPN patients with COVID-19Tiziano Barbui, Alessandra Iurlo, Arianna Masciulli, et al.
American Journal of Hematology|September 16, 2022
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19Tiziano Barbui, Alessandra Carobbio, Arianna Ghirardi, et al.
Blood Cancer Journal|November 15, 2022
Breakthrough infections in MPN-COVID vaccinated patientsTiziano Barbui, Alessandra Carobbio, Arianna Ghirardi, et al.
Leukemia|January 22, 2022
Second versus first wave of COVID-19 in patients with MPNTiziano Barbui, Alessandra Iurlo, Arianna Masciulli, et al.
Allergy|October 30, 2024
EAACI guidelines on the management of IgE-mediated food allergyAlexandra F Santos, Carmen Riggioni, Ioana Agache, et al.
Pageof 39